Evidence-based policy recommendations on cancer screening and prevention

Cancer Detection and Prevention

Volumn 26, Issue 5, 2002, Pages 350-361

  Franco, Eduardo L ^a   Duarte Franco, Eliane ^a   Rohan, Thomas E ^b  

^a MCGILL UNIVERSITY   (Canada)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer; Evidence based medicine; Prevention; RCTs; Recommendations; Screening

Indexed keywords

EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; HUMAN; MANAGEMENT; MASS SCREENING; NEOPLASM; PRACTICE GUIDELINE; PREVENTIVE MEDICINE; REVIEW;

EVIDENCE-BASED MEDICINE; HEALTH POLICY; HUMANS; MASS SCREENING; NEOPLASMS; POLICY MAKING; PRACTICE GUIDELINES; PREVENTIVE MEDICINE;

EID: 0036914602     PISSN: 0361090X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-090X(02)00118-6     Document Type: Review

References (52)

1. Schatzkin A. Intermediate markers in cancer research: Theoretical and practical issues in the use of surrogate endpoints. In: Franco EL, Rohan TE, editors. Cancer Precursors: Epidemiology, Detection, and Prevention. New York: Springer; 2002. p. 46-59.
2. Kelloff GJ, Sigman C. Chemoprevention. In: Franco EL, Rohan TE. editors. Cancer Precursors: Epidemiology, Detection, and Prevention. New York: Springer; 2002. p. 374-88.
3. Screening for Cancer PDQ® Screening/Detection - Health Professionals. http://cancer.gov/templates/list.aspx?viewid=33641db3-9099-4705-a77d- 590a60637451. Accessed 10 May 2002.
4. Kramer BS. NCI state-of-the-art statements on cancer screening. In: Greenwald P, Kramer BS, Weed DL, editors. Cancer Prevention and Control. New York: Marcel Dekker; 1995. p. 721.
5. Baines CJ, Miller AB. Mammography versus clinical examination of the breasts. J Natl Cancer Inst Monogr 1997;22:125-9.
6. Olsen O, Gotzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet 2001;358:1340-2.
7. Miettinen OS, Henschke CI, Pasmantier MW, et al. Mammographic screening: No reliable supporting evidence? Lancet 2002;359:404-5 (an extended version can be found in: http://image.thelancet.com/extras/1093web.pdf).
8. La Vecchia C, Franceschi S, Decarli A, et al. Pap smear and the risk of cervical neoplasia: Quantitative estimates from a case-control study. Lancet 1984;2:779-82.
9. Herrero R, Brinton LA, Reeves WC, et al. Screening for cervical cancer in Latin America: A case-control study. Int J Epidemiol 1992;21:1050-6.
10. Laara E, Day NE, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: Association with organised screening programmes. Lancet 1987;1:1247-9.
11. Benedet JL, Anderson MB, Matisic JP. A comprehensive program for cervical cancer detection and management. Am J Obstet Gynecol 1992;166:1254-9.
12. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
13. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71.
14. Winawer SJ, Flehinger BJ, Schottenfeld D, et al. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst 1993;85:1311-8.
15. Mandel JS, Church TR, Ederer F, et al. Colorectal cancer mortality: Effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999;91:434-7.
16. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: Clinical guidelines and rationale. Gastroenterology 1997;112:594-642.
17. Winawer SJ, Zauber AG, Ho MN, et al. The National Polyp Study Workgroup: Prevention of colorectal cancer by colonoscopic polypectomy. New Engl J Med 1993;329:1977-81.
18. Rembacken BJ, Fujii T. Cairns A, et al. Flat and depressed colonic neoplasms: A prospective study of 1000 colonoscopies in the UK. Lancet 2000;355:1211-4.
19. Lieberman DA, Weiss DG, Bond JH, et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer: Veterans Affairs Cooperative Study Group 380. New Engl J Med 2000;343:162-8.
20. Imperiale TF, Wagner DR, Lin CY, et al. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. New Engl J Med 2000;343:169-74.
21. Prorok PC, Andriole GL, Bresalier RS, et al. The prostate, lung, colorectal and ovarian cancer screening trial project team: Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials 2000;21:273S-309S.
22. Nanda K, McCrory DC. Myers ER, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: A systematic review. Ann Int Med 2000;132:810-8109.
23. Cuzick J, Sasieni P, Davies P, et al. A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: Summary and conclusions. Br J Cancer 2000;83:561-5.
24. Henschke CI. McCauley DI, Yankelevitz DF, et al. Early Lung Cancer Action Project: Overall design and findings from baseline screening. Lancet 1999;354:99-105.
25. Marcus PM, Bergstralh EJ, Fagerstrom RM, et al. Lung cancer mortality in the Mayo Lung Project: Impact of extended follow-up. J Natl Cancer Inst 2000;92:1308-16.
26. US Preventive Services Task Force. Guide to Clinical Preventive Services, 2nd Ed. Washington, DC: US Department of Health and Human Services; 1996/2002. http://www.ahcpr.gov/clinic/uspstfix.htm. Accessed 10 May 2002.
27. Canadian Task Force on Preventive Health Care. The Canadian Guide to Clinical Preventive Health Care. Canada, Ottawa: Health Canada; 1994. http://www.ctfphc.org. Accessed 10 May 2002.
28. Anonymous. Colorectal cancer screening. Recommendation statement from the Canadian Task Force on Preventive Health Care. Can Med Assoc J 2001;165:206-8.
29. Levine M, Moutquin JM, Walton R, et al. Chemoprevention of breast cancer: A joint guideline from the Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative's Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Can Med Assoc J 2001;164:1681-90.
30. Ringash J. Preventive health care, 2001 update: Screening mammography among women aged 40-49 years at average risk of breast cancer. Can Med Assoc J 2001;164:469-76.
31. Baxter N. The Canadian Task Force on Preventive Health Care: Preventive health care, 2001 update: Should women be routinely taught breast self-examination to screen for breast cancer? Can Med Assoc J 2001;164:1837-46.
32. Chalmers I. The Cochrane Collaboration: Preparing, maintaining and disseminating systematic reviews of the effects of health care. In: Warren KS, Mosteller F, editors. Doing more good than harm: the evaluation of health care interventions. Ann New York Acad Sci 1993;703:156-63.
33. Abstracts of Cochrane Reviews. The Cochrane Library Issue 4; 2000. http://www.update-software.com/cochrane/cochraneframe.html. Accessed 10 May 2002.
34. McCrory DC, Matchar DB, Bastian L, et al. Evaluation of cervical cytology. Evidence report/technology assessment no. 5. AHCPR Publication No. 99-E010. Agency for Health Care Policy and Research, US Department of Health and Human Services, Rockville, MD, February 1999.
35. Agency for Health Care Policy and Research. Colorectal cancer screening. Technical review 1. AHCPR Publication No. 98-0033. US Department of Health and Human Services, Rockville, MD, May 1998.
36. Noorani HZ, Arratoon C, Hall A. Assessment of Techniques for Cervical Cancer Screening. Canadian Coordinating Office for Health Technology Assessment, Ottawa, May 1997.
37. Cuzick J, Sasieni P, Davies P, et al. A systematic review of the role of human papillomavirus testing within a cervical screening programme. Health Technol Assess 1999;3:1-199.
38. Payne N, Chilcott J, McGoogan E. Liquid-based cytology in cervical screening: A rapid and systematic review. Health Technol Assess 2000;4:1-73.
39. Hubbard SM, Shields VT, Thurn AL. Information systems in oncology. In: Devita VT, Hellman S, Rosenberg SA, editors. Cancer: Principles and Practice of Oncology, 5th Ed. Philadelphia: Lippincott-Raven; 1997. p. 2983-91.
40. National Cancer Institute. CancerNet PDQ(r) Cancer Information Summaries: Prevention. http://cancernet.nci.nih.gov/pdq/pdq_prevention.shtml. Accessed 10 May 2002.
41. Gail MH, Costantino JP, Bryant J, et al. Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. J Natl Cancer Inst 1999;91:1829-46.
42. Janne PA, Mayer RJ. Chemoprevention of colorectal cancer. New Engl J Med 2000;342:1960-8.
43. Pike MC, Ross RK. Progestins and menopause: Epidemiological studies of risks of endometrial and breast cancer. Steroids 2000;65:659-64.
44. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group: The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. New Engl J Med 1994;330:1029-35.
45. Omenn GS, Goodman GE, Thornquist MD. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. New Engl J Med 1996;334:1150-5.
46. IARC Handbook of Cancer Prevention. Carotenoids, vol. 2. Lyon: World Health Organization, International Agency for Cancer Research; 1998.
47. Cochrane Tobacco Addiction Group. Abstracts of Cochrane Reviews. The Cochrane Library Issue 2, 2002. http://www.updatesoftware.com/abstracts/g160index.htm. Accessed 10 May 2002.
48. Cochrane Gynaecological Cancer Group. Abstracts of Cochrane Reviews. The Cochrane Library Issue 2, 2002. http://www.updatesoftware.com/abstracts/ab001035.htm. Accessed 10 May 2002.
49. National Institutes of Health Consensus Development Conference Statement: Breast cancer screening for women ages 40-49, 21-23 January 1997. National Institutes of Health Consensus Development Panel. J Natl Cancer Inst 1997;89:1015-26.
50. Taubes G. NCI reverses one expert panel, sides with another. Science 1997;276:27-8.
51. Anonymous. Breast cross-examination. Can Med Assoc J 2001;165:261.
52. American Cancer Society. ACS Cancer Detection Guidelines - Cancer-related Check-up. http://www.cancer.org/eprise/main/docroot/PED/content/PED_2_3X_ACS_Cancer_ Detection_Guidelines_36. Accessed 10 May 2002.